Alpha Tau Medical Ltd. (DRTS) stock
DRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as DRTSW
$13.38+0.02 (+0.15%)
Close on Nov 13, 2026Market cap $1.18BP/E –Yield –
Alpha Tau Medical r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $32.07M, up 18.7% from the year before. The highest annual figure on record is $32.07M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.07M | +18.7% |
| FY2024 | Dec 31, 2024 | $27.02M | +2.3% |
| FY2023 | Dec 31, 2023 | $26.42M | +26.5% |
| FY2022 | Dec 31, 2022 | $20.89M | +82.5% |
| FY2021 | Dec 31, 2021 | $11.45M | +51.7% |
| FY2020 | Dec 31, 2020 | $7.54M | +13.7% |
| FY2019 | Dec 31, 2019 | $6.64M | – |
See a number that looks wrong?